ASIA-PACIFIC WESTERN BLOTTING MARKET 2019-2027

MARKET OUTLOOK
The market for western blotting in the Asia-Pacific region is expected to make progressive growth with 6.80% of CAGR throughout the estimated period 2019-2027.
Japan, China, India, South Korea, Australia & New Zealand, ASEAN countries and countries in rest of APAC together form the western blotting market for the Asia-Pacific region.
Japan is a country that has a low prevalence of HIV, with a concentrated epidemic amongst high-risk groups. Whether the country meets the 90-90-90 goals set by the Joint United Nations Program on HIV/AIDS (UNAIDS)/WHO has however, not been determined. The growing stigma around HIV and a means to completely eradicate the disease is hampered, as new HIV cases in the country have been identified. A total of 1,407 people were newly-infected with HIV in 2017, and the figure was only slightly lower than 2016; one-third of those affected showed symptoms indicating progression to the third stage of the disease, as stated by the data from the health ministry. Additionally, the increasing cases of HIV AIDS, coupled with the endemic Lyme disease, are boosting the western blotting market in Japan.
Japan is also the second-largest pharmaceutical market that contributed to 9.7% of the world pharmaceutical market share in 2013. In addition, with growing partnerships & collaborations between universities and pharma companies, the pharmaceutical R&D sector is emerging in the Japanese market. Thus, such collaborations and the flourishing Japanese pharmaceutical industry are increasingly encouraging the demand for western blotting required for research activities.
COMPETITIVE OUTLOOK
The key companies profiled in the report include F. Hoffman La-Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Technologies, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., GE Healthcare and Li-Cor, Inc.

TABLE OF CONTENT
1. ASIA-PACIFIC WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. ASIA-PACIFIC DOMINATES THE OVERALL WESTERN BLOTTING MARKET
2.2.2. GROWING NUMBER OF APPLICATIONS FOR WESTERN BLOTTING
2.2.3. GROWING ACCEPTANCE OF DIGITAL WESTERN BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3. WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4. WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5. WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6. WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. ASIA-PACIFIC
6.1.1. CHINA
6.1.2. JAPAN
6.1.3. INDIA
6.1.4. SOUTH KOREA
6.1.5. ASEAN COUNTRIES
6.1.6. AUSTRALIA & NEW ZEALAND
6.1.7. REST OF ASIA-PACIFIC
7. COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC, INC.
7.4. BIO-RAD TECHNOLOGIES, INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY, INC.
7.7. GE HEALTHCARE
7.8. LI-COR, INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS, INC.
7.11. PERKINELEMER, INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL, INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN, INC.
7.15. ROCKLAND IMMUNOCHEMICALS, INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY



LIST OF TABLES
TABLE 1. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 5. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 6. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)
TABLE 7. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY END-USER, 2019-2027 (IN $ MILLION)




LIST OF FIGURES
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 3. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2019-2027 (IN $ MILLION)
FIGURE 4. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $ MILLION)
FIGURE 5. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 6. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 9. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 10. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 13. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 15. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 16. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 18. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY AGRICULTURE, 2019-2027 (IN $ MILLION)
FIGURE 19. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2019-2027 (IN $ MILLION)
FIGURE 20. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
FIGURE 21. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2019-2027 (IN $ MILLION)
FIGURE 23. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2019-2027 (IN $ MILLION)
FIGURE 24. ASIA-PACIFIC WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 25. CHINA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26. JAPAN WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27. INDIA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 28. SOUTH KOREA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29. ASEAN COUNTRIES WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 30. AUSTRALIA & NEW ZEALAND WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 31. REST OF ASIA-PACIFIC WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)